Patent ID: 8719049

Claim:
An automated method of reporting payments made to patients for their participation in a clinical study in a blinded manner to the sponsor of the clinical study, the clinical study having a plurality of investigative sites which perform activities in accordance with the protocol of the clinical study, each patient having patient ID information and being assigned a subject ID that de-identifies the patient, the method comprising: (a) receiving payment requests at a software application executing on one or more computer processors from the investigative sites associated with patient activity, the software application executing on the one or more computer processors including for each patient that is participating in the clinical study, the patient ID information, and the de-identified subject ID, the payment requests being associated with the patient ID information, the payment requests being requests to make payments to patients for their participation in the clinical study, and wherein approved payment requests are reported on blinded payment reports; (b) processing the payment requests at the software application executing on the one or more computer processors, and approving payments that conform to activities performed in accordance with the protocol of the clinical study and in line with regulatory guidelines and approved budgets for the clinical study, the approved payments being payments made to patients for their participation in the clinical study; and (c) generating by the software application executing on the one or more computer processors the blinded payment reports for electronic delivery to the sponsor, each blinded payment report showing at least: (i) the de-identified subject ID for each approved payment, (ii) the payment amounts for each approved payment, and (iii) date associated with each approved payment, each blinded payment report including approved payments made for a plurality of de-identified subject ID's, wherein the approved payments are payments made to patients for their participation in the clinical study.